Mereo BioPharma Group plc
MREO
$2.74
$0.2811.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -82.90% | 53.02% | -22.37% | -36.93% | 1.73% |
| Total Depreciation and Amortization | -1.46% | -2.84% | 9.73% | -6.55% | -2.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 237.00% | -140.86% | 252.32% | 11.14% | -47.10% |
| Change in Net Operating Assets | -159.98% | 162.06% | -183.14% | 210.29% | 28.39% |
| Cash from Operations | 11.58% | -25.28% | 4.87% | 1.09% | -17.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 100.14% | -- |
| Cash from Investing | -- | -- | -100.00% | 100.14% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -62.50% | 93.27% | -171.23% | -- | -- |
| Cash from Financing | 1,155.00% | 93.27% | -101.27% | -- | -- |
| Foreign Exchange rate Adjustments | 172.06% | -204.65% | 1,225.23% | -52.86% | -104.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.73% | -55.16% | -117.82% | 542.54% | -71.52% |